Lexogen is supporting the virtual RNA Society Meeting 2021 – Watch our Sponsored Talk recording!
4. May 2021
Watch the Sponsored Talk recording The 26th annual RNA Society Meeting is taking place virtually from May 25th to June
News & Blog
Read More ›
Webinar: CaTCH it if you can! CRISPRa Tracing of Therapy Resistant Cancer Cell Clones
29. April 2021
Watch the recording Learn more about QuantSeq 3′ mRNA-Seq Library Prep Kit. Abstract The emergence of cell clones that are
Webinar: Deep Phenotyping of the Human Liver for NAFLD (NASH) Target Discovery
12. April 2021
Watch the recording Learn more about Lexogen Services. Abstract ‘Big data’ is delivering on its promise to improve drug development, with
Lexogen is taking part in the virtual AGBT 2021!
12. February 2021
We are more than excited to be part of this year’s virtual AGBT Meeting (March 1–3, 2021)! Advances in Genome
Lexogen is here to help: tools for SARS-CoV-2 research
2. February 2021
The new coronavirus variant The recent global outbreak of the novel coronavirus, SARS-CoV-2, has researchers focusing their attention on understanding
mRNA sequencing with CORALL
13. January 2021
Lexogen now offers CORALL mRNA-Seq bundles including poly(A) selection providing a convenient complete workflow solution for mRNA-Seq library preparation. Features
Lexogen Webinar: LUTHOR – unparalleled sensitivity in single cell sequencing
19. November 2020
Watch the recording Learn more about LUTHOR 3’ mRNA-Seq Library Prep Kit Abstract Cell-to-cell variability is a fundamental feature among
RNA Society and RNA Expert Lexogen Continue Their Successful RNA Salon Collaboration to Support Thousands of Researchers World-Wide
19. November 2020
In 2020, the molecule RNA (ribonucleic acid) has moved into the center of worldwide attention with the COVID 19 pandemic
COVID-19: a solution exists to prevent lockdowns and economic collapse!
17. November 2020
Mass screening is the best solution to master the pandemic, prevent lockdown and come back to normality. This strategy will
Lexogen has developed the first commercial Covid-19 ultra-high-throughput test for true public health mass screening
12. November 2020
Vienna, Austria, November 12, 2020 /PRNewswire/ – Lexogen GmbH, a Vienna-based market leader in Next-Generation Sequencing (NGS) and transcriptomics announced
Lexogen Introduces LUTHOR 3’ mRNA-Seq Library Prep Kit for Ultra-Low Input and Single-Cell Sequencing
22. October 2020
Explore Further by Detecting Twice as Many Genes per Cell Vienna, October 22, 2020 /PRNewswire/ – Lexogen, a transcriptomics and
Webinar: Probing and Disrupting Oncogenic Gene Control via Targeted Protein Degradation
15. October 2020
Watch the recording Learn more about Lexogen’s Corall Total RNA-Seq Library Prep Kit Abstract This webinar outlines the use of targeted
Categories
Lexogen GmbH
Campus Vienna Biocenter 5
1030 Vienna, Austria
Telephone:
+43 (0) 1 345 1212
Sales support:
+43 (0) 1 345 1212-42
Technical support:
+43 (0) 1 345 1212-41
Working hours: 9:00 – 17:00 (CET)
Fax: +43 (0) 1 345 1212-99
Email: info@lexogen.com
Company number: FN 297318 h
VAT number: ATU63622048
Lexogen, Inc.
51 Autumn Pond Park
Greenland, NH 03840, US
Telephone:
+1-603-431-4300 ext.0
+1-877-Lexogen
(+1-877-539-6436) ext. 0
Sales inquiries:
Northeast: +1-312-978-6413
Southeast: +1-615-968-3325
Northwest: +1-415-726-4318
Southwest: +1-520-934-0678
Technical support:
+1-949-767-1631
(Working hours: 9:00 – 17:00 (EST))
+1-603-498-1666
(Working hours: 7:30 – 15:30 (CST))
Fax: +1-603-431-4333
Lexogen Newsletter
Subscribe to our mailing list to be among the first to get updates from us!
Copyright © 2026 Lexogen GmbH. All rights reserved | Impressum | Privacy Policy | Terms and Conditions | Whistleblowing
Cart
Product
Product Short Description
PRICE
Product
Product Short Description
PRICE
Product
Product Short Description
PRICE